Phage Organizations

A Collaborative Network of African phage researchers to promote and sensitize phage research in Africa.

Vision: To improve human lives through phage research.

Mission Statement: To provide a platform that encourages scholarship, collaboration and mentorship among researchers and for the advancement of phage research in Africa.

Who are we? We are African phage researchers in early and mid-career level, brought together while seeking solutions to the common challenges we were facing as phage scientists in the developing world/third world. In our quest we realized that there are more phage scientists in Africa, working in isolation and facing the same challenges. To this end we formed the platform; African Phage Forum (APF) for phage researchers in Africa to engage (share ideas, experiences, resources, opportunities) and network with a common goal of improving human life through phage research.

What we will do?

1. Motivate and mentor phage research students (undergraduate/postgraduate) in African Universities:

• Share affordable protocols for efficient phage experimental processes
• Link to affordable commercial phage research service providers e.g. for sequencing, TEM etc
• Form North-South collaborations for possible support on phage research services e.g TEM

2. Encourage and work towards South-South multidisciplinary collaborative work among phage scientists in a bid to solve problems tailored to African context.

3. Bridging phage research and policy implementation at national levels, using research-based evidence to improve development policy, programs and practice.

Amarex designs and conducts clinical trials for phage products.

BDDC’s mission is to help get phage therapies to patients, agriculture, animals. We apply PhD-level phage scientific knowledge, over 20 years of drug & phage therapy development experience (market approval of 7 medicines), and funding award know-how to advance phage-based and phage-derived therapeutics from lead identification to licensure .

We are working on bacteriophages of ESKAPE pathogens group and on the phages of Xanthomonas axonopodis. We have a team of undergrad and graduate students working on phage isolation, characterization and genome analysis.

Our mission is to provide on-demand phage expertise, training and wet lab services to biotech companies.

Education and Scientific Resaerch

We are a research group composed of university professors and government-funded scientists, dedicated to research and biotechnology transfer to the productive sector. Our work focuses on the development of sustainable biocontrol strategies for fermentations and other industrial processes, based on the use of bacteriophages.

Expertise in phage product development, through 11 years of experience in discovery, preclinical, clinical and regulatory activities dedicated to phage therapy

We’re working on developing and offering phage into the aquatics industry; specifically the food industry.

At Biotrial Inc., we provide opportunities for healthy volunteers to participate in paid medical research studies and clinical trials that test new drugs and medical devices.

CECAV, located in Spain, is a center working for the agri-food sector that integrates all the the poultry production chain: feed manufacturing, primary production in farms and slaughterhouses.

The objective of CECAV is give to sector, in collaboration with the Public Administration, the necessary tools to guarantee Animal Health (especially poultry) and the quality of animal products (especially poultry), from feed manufacturing to slaughterhouses, including primary production on farms.

One of the main research lines in the R&D is the use of phages in the poultry sector.

Cell Origins provides researchers with critical phage display services and phage-based kits. We take on small and large projects including consulting, phage display selection and screening, and library construction. We also offer premade peptide phage display libraries of proven high quality. We are currently developing a product for the identification and phenotypic characterization of commonly used cell lines.​

Manufacturer of single use disposable bioreactors for phage amplification

We are a group of US-trained specialists in Nepal, setting up our own multi-specialty center named as “Center for American Medical Specialists (CAMS)” which also hosts an advanced molecular lab with a focus on Infectious diseases. Since we have a big burden of AMR in Nepal & do not have many therapeutic options, we are interested in exploring on Phage-Therapy. As of now, we have formed a team of Infectious Diseases doctors, phage scientists, molecular biologist, microbiologist, pharmacists & epidemiologist too. We want to start with therapeutic clinical research in collaboration with phage-producers & soon, plan to build up our own phage-bank in Nepal.

CollegeEssay.org is a professional academic writing service dedicated to helping students excel in their studies. It offers expertly crafted essays, research papers, dissertations, and more, ensuring originality and quality. With a team of experienced writers, timely delivery, and affordable pricing, the platform provides reliable student help for various academic needs. Additionally, its AI Essay Writer tool allows users to generate essays quickly and efficiently.

CreatiPhage is committed to developing innovative phage-based medicines and personalized therapies to address the global threat of antimicrobial resistance.

Creative Bioarray is an innovative biotechnology company whose mission focuses on developing unique technologies that provide global scientists with high quality products and satisfactory services to facilitate the investigation of life science researches.

As a scientists-founded and scientists-driven leading biotechnological company, Creative Biogene focuses on developing high quality products and services, as well as proprietary technology to support the research in the field of basic life sciences research, biomedical development, industrial synthetic application and preclinical drug discovery.

Creative Biolabs has long been devoted to the development and application of phage display technology. With years of experience, our scientists have developed several phage display-based platforms and tailored hundreds of particular libraries and thousands of specific antibody products to boost our global customers’ research and project goals.

Creative Biolabs has engaged in phage research for many years, providing services like phage detection, identification, and discovery, small and large-scale phage production, phage purification, phage-based vaccine development, and phage-based therapeutics discovery to assist academic and industry intuitions whose activities are based on bacteriophage functions to fight and prevent bacterial infections and other diseases.

Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. We provide contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. Our goal is to be a trusted source for all your assay development and manufacturing needs.

Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. We provide contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. Our goal is to be a trusted source for all your assay development and manufacturing needs.

We as a Public Funded Drug Research Institute of India, carry extensive research on Infectious Disease, Non Communicable diseases and develop Formulations, Innovate the pharmaceuticals products and scale up the Pharmaceutical Manufacturing Technologies for strengthening Public Health Sector.

Cytophage is a biotechnology company that develops bacteriophage products as an alternative to antibiotics to prevent and treat bacterial and viral infections that affect human health, animal health and food security

The University of Northern Iowa Department of Biology serves the state of Iowa by preparing the next generation of highly qualified graduates for opportunities in the life sciences, readying them for careers in healthcare, education, scientific research, and natural resource management. Our lone virologist, Michael H. Walter, characterizes phages of Bacillus anthracis/cereus derived from Iowa Prairie soils. Research foci include phage physical durability under conditions potentially found in therapy applications. We are also examining phage durability and possible increase in macrophages defense cells.

We are developing new affinity-based diagnostic assays

We are one of the few centers in the world dedicated to phage therapy. It is part of the Eliava Institute of Bacteriophages, Microbiology and Virology, a research facility with broad experience in bacteriophage science and applications since 1923.

The Eliava Phage Therapy Center has specialists in the fields of Pediatrics, Internal Medicine, Urology, Gynecology and offers outpatient surgical consultations whose treatment strategies emphasize the use of bacteriophage as the cornerstone of complex medical service.

ExoLytics is an early-stage biotechnology startup focused on developing novel, innovative, and disruptive technologies to combat drug-resistant bacterial diseases. The Company harnesses endolysins, enzymes present in nature, to engineer safe, rapid, targeted, and effective antimicrobial therapies. The rise in antimicrobial drug resistance (AMR), coupled with shrinking treatment options, will challenge global public health and create new, untapped, market opportunities. ExoLytics aims to play a critical role in worldwide efforts to develop and commercialize alternatives to antibiotics.

The goal of the Fagenbank is to develop phage therapy together with doctors.

The Fagenbank is a non-profit initiative at the Delft University of Technology, The Netherlands.

Our mission is to stimulate research into the efficacy and safety of bacteriophage therapy as a treatment method for antibiotic-resistant infections.

Fagoterapia LAB s.r.l. is the first Italy-based start up developing antimicrobial therapy based on bacteriophages and their derivatives for treating antibiotic-resistant infections by using innovative tools of artificial intelligence for either standard or personalised cures.

FasoPhage is a section of the Laboratory of Emerging and Re-emerging Pathogens. There are well-characterized clinical multidrug-resistant bacterial strains in the bacterial bank of the laboratory. FasoPhage is intending to use these MDR bacteria to isolate and establish phage library in Burkina Faso, particularly in the city of Bobo-Dioulasso for better control of antimicrobial resistance.

We are a research group committed to isolate, characterize, and engineer bacteriophages and phage derived proteins for detection and control of gram-negative pathogens. We are currently collecting phages for research and we would be happy to contribute to phage applications in agriculture, food, and medicine.

Supporting and promoting the development of modern information, communication and industrial technologies.

Advancing Florida citrus research to eliminate the threats of the Asian Citrus Psyllid and Citrus Greening

Focuses on synthetic biology using and producing phosphate analogues. Has technology for the production of phosphorothioate single stranded phage DNA. Interested in those who make phage DNA.

State university. An institution for education and research.

GSD Bio is committed to preventing epidemics by enabling low-cost vaccines that can be quickly scaled and produced at point-of-need. We are developing the SEED system (lactococcal phage-vectored vaccine production) for simplified protein production that uses food-safe ingredients and a bacterium used globally in food.

Research to support positive clinical outcomes

We are passionately dedicated to developing a cutting-edge solution for eradicating AHPND in shrimp. By harnessing the immense potential of bacteriophages, we are at the forefront of research and innovation in the field of aquaculture disease control.

Ibadan Bacteriohage Research Team is an undergraduate research group of the University of Ibadan, registered under the HHMI SEAPHAGES early career research programme. The team is focused on active engagement in bacteriophage research, to achieve the vision of bacteriophage therapy as an alternative to antibiotics use in Africa. This is achieved through bacteriophage exploration, characterization and research collaborations. The team is driven by a strong commitment to bridge the existing knowledge gap of undergraduate students in bacteriophage biology and the role of computational biology in addressing the imminent global challenge of antimicrobial resistance.

IHMA is a premier provider of antimicrobial drug development services. Our mission is to utilize our extensive laboratory and industry expertise to support efficient and effective anti-infective product development.

As a central microbiology laboratory, IHMA offers a full suite of clinical microbiology services and phage testing capabilities to provide a one-stop source of services that greatly reduces laboratory, logistical, communication, and data coordination challenges.

In addition to our full complement of conventional and molecular microbiology capabilities IHMA offers a variety of critical phage testing services in support of phage-based therapeutics.

• Phage plaquing assays
• Pre-clinical profiling of phage activity against target species in our extensive and current clinical bacterial isolate repository
• Evaluating in vitro effectiveness of phage products against target bacterial species as part of clinical trials
• Determination of phage concentrations in various clinical specimens (e.g. blood, urine, etc.) for clearance and pK analysis
• Ability to develop or adopt new methods beyond plaquing (e.g. liquid-based, automation, qPCR, etc.)
• Design and implement validation studies to determine stability of phage in biological samples over time, transport conditions, and specimen processing protocols

National Centre for Veterinary Type Cultures, ICAR-NRCE, Hisar. We are a bacteriophage culture collection and isolate, characterize and preserve bacteriophages for future applications

Phage dosage optimization, Customized Phage Therapy

IBRC aims to build a consortium of scientists, academia, clinicians, and researchers to collaborate and contribute towards phage therapy and other areas of bacteriophage research. By leveraging the expertise and resources of the consortium, we hope to make phage therapy a safe and acceptable solution.

Our goal is to break the dependence of phages and host bacteria. Specifically, we are synthesizing phages completely in vitro and independent of the original pathogenic host. This solves three things:

1. Purity (our systems increases the ratio of phages to endotoxins by 100x)
2. Scalability of production (one system for all phages)
3. Throughput of phage engineering (no homologous recombination)

JAFRAL is manufacturing phages to highest quality/purity. It can also develop manufacturing process and analytical methods for various types of bacteriophages.

LamdaGen’s plasmonic biosensors enable high sensitivity detection systems that can provide rapid screening of phage libraries, phage development and QC, and efficacy monitoring, thereby accelerating implementation of phage based mitigations and therapies across several application areas.

Lawrence Livermore National Laboratory (LLNL) was established in 1952 (as the “Big Ideas” Laboratory) in the early days of the Cold War to meet urgent national security needs by advancing nuclear weapons science and technology. At LLNL, we apply cutting-edge science and technology to achieve breakthroughs in enterprise resilience and counterterrorism, defense and intelligence, energy security and climate resilience and research and development to produce fundamental science discoveries and faster innovation cycles.

The DSMZ is an internationally renowned open access culture collection (BRC = Biological Resource Centre) and WFCC member, belongs to the German public services and operates according to the OECD BRC Best Practice Guidelines. The DSMZ is publicly funded and provides more than 70.000 different bioresources to the scientific community for an adequate fee. Recipients must be legally authorized to work with the respective bioresource. DSMZ bioresources including phages are not for direct human use or similar direct applications but for laboratory purposes only. The DSMZ Terms and a MTA apply upon each single order, commercial purposes are excluded but may be negotiated on legal Level with the DSMZ. All orders must be written and sent to the DSMZ customer service department.
The DSMZ collects all kinds of phages to preserve them for the long-term and to keep them authentic. Phages will not be purified above laboratory batch level for direct application. All phages are welcome to be deposited with the DSMZ. See DSMZ microorganisms catalogue homepage for available phages.

"We are the only manufacturer of bacteriophages in Central Asia LLC ““AZIYA IMMUNOPREPARAT””. Today it produces medicinal products under the brand MediPhag

1. Bacteriophage staphylococcal liquid ““MediPhag”” Spray 20ml
2. Bacteriophage staphylococcal liquid ““MediPhag”” 20ml № 4
3. Dysentery bacteriophage polyvalent ““MediPhag”” 20 ml № 4 - liquid for oral administration and oral administration
4. Bacteriophage dysentery polyvalent ““MediPhag”” capsules for oral administration
   № 10
5. Salmonella polyvalent bacteriophage ““MediPhag”” 20 ml № 4 - liquid for oral administration and rectal administration.
6. Salmonella polyvalent bacteriophage ““MediPhag”” capsules for oral administration. № 10.
   We are looking for partners for commercial purposes"

Lxbio Pharmaceuticals is a Portuguese biotechnology company dedicated to developing innovative biopharmaceutical solutions, with a particular focus on phage therapy. Their mission is to revolutionize disease treatment and prevention, enhancing global quality of life through sustainable and ethical practices.

Mary Ann Liebert, Inc. is a leading independent publisher of scientific, technical, and medical content, known worldwide for its prescience and establishment of authoritative peer-reviewed journals, books, and trade publications in cutting-edge fields such as biotechnology, biomedical research, medicine and surgery, public health research and policy, technology and engineering, law, environmental research and policy, and other specialized disciplines. The company publishes over 90 peer-reviewed journals, leading trade magazines, and specialized newsletters, in addition to society membership management and conferences.

Mary Ann Liebert, Inc. identifies and nurtures critical topics and cutting-edge fields by creating first-to-market, specialized publications that play a vital role in advancing research and facilitating collaboration in academia, industry, and government. The company is deeply committed to ensuring the highest quality content and is able to invest for the long-term, supporting publications in emerging markets through to maturity.

Research, development, and manufacturing of bacteriophages. GMP certified producer. Ready to collaborate to introduce the bacteriophages to the world.

Development and production of phage cocktails for food safety application.

Micreos is a platform biotech company focused on discovering and developing recombinant proteins and phage-based antimicrobial vectors to target AMR pathogens in infectious diseases, dermatology, and oncology.

Mikroliz Therapeutic Bacteriophage Bank (MTBB) is established in Turkey which currently has over 800 phages against mainly the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp) pathogens. MTBB is constantly growing with new phages and we are developing quick methods for phage isolation and characterization. Our three-year project titled “Therapeutic Bacteriophage and Lytic Enzyme Bank against Superbugs” is supported by government,TUBITAK (The Scientific and Technological Research Council of Turkey).

Provide precision instruments for life sciences

We have developed DNA-based therapeutics which can inactivate antibiotic resistance in bacterial pathogens. Administered with or before antibiotics they can be used to treat and prevent infections with antibiotic resistant bacteria.

We have developed DNA-based therapeutics which can inactivate antibiotic resistance in bacterial pathogens. Administered with or before antibiotics they can be used to treat and prevent infections with antibiotic resistant bacteria.

Nukamel is a nutritional company developing and producing young animal feeding concepts based on dairy and other high-quality raw materials. The main products are milk replacers, half-concentrates and nutritional emulsifiers for the animal feed industry with a strong focus on calves, piglets and poultry. Our focus is to support the sector in promoting animal growth and health, thereby recuding the need for antibiotics.

PBD Biotech is a pioneer in phage-based diagnostics. It is developing a rapid test for tuberculosis that detects the presence of live mycobacteria in a blood sample. The test called Actiphage offers potential for early diagnosis of active disease progression.

I work with skin microbiome and would like to expolore if Phage therapy can be an option for treating infections and microbiome mediated diseases.

Phage Arab is a scientific platform dedicated to building a strong Arab community of researchers, scientists, research centers, and companies working in phage therapy. Our mission is to connect and support Arab experts in this field by sharing key knowledge, research papers, and fostering collaboration.

We make complex scientific findings accessible in Arabic. We also highlight the contributions of Arab researchers and facilitate discussions, webinars, and networking opportunities to advance phage therapy in the Arab world.

Phage Directory is a platform that brings together researchers, medical professionals, and biotechs to advance research in phages and phage therapy.

We are observing any progress in phagetherapy & phage research and are helping patients to find phages and get a proper phage treatment (case-management). We are, too, trying to encourage and enable family physicians and pharmacists to go for pt. We are further helping clinics to set up a phage unit, consisting of their microbio lab, the pharmacy and clinicians of all kind to the benefit of their patients (project-management).
Happy to join this phantastic network!

support australians with information and funding for phage therapy still in the conceptual stage hope to be up and running after 12 montrhs

PhagePro is a phage company that prioritizes global health. Our mission is to alleviate the burden of antibiotic resistance in vulnerable communities.

PhagoMed Biopharma GmbH is an Austrian biotech company focused on the development of human therapeutic applications of phages and phage-derived proteins. Currently, PhagoMed has three active development programs in the fields of periprosthetic joint infections, urinary tract infections and bacterial vaginosis. These development programs are based on the experiences of its clinical co-founders with last-resort treatments, as well as research collaborations with highly renowned scientists and research institutions in Germany and Belgium. Since its incorporation in November 2017, the company has raised more than €5.5 million in private investments and public grants. PhagoMed has a team of twelve highly skilled scientist working on its programs, eight of which at the Campus Vienna Biocenter in Vienna, Austria.

Democratize phage use - Starting in aquaculture

The PRI is the European Microbiome Regulatory Science Expertise Center, created in 2010 to support the development and registration of therapeutic and diagnostic products emerging from microbiome science.

We work to educate and contribute to the conditions of success for future medicinal innovations emerging from microbiome science, and our ultimate objective is to see these therapeutic innovations achieve EU marketing authorization, thereby giving European patients access to registered microbiome-based medicinal products or validated diagnostics.

The Phase Genomics ProxiMeta™ sequencing platform employs proximity ligation technology to significantly improve de novo binning and host attribution of bacterial and phage genomes recovered from complex metagenomic samples.

PrecisionPhage provides bioinformatic services for phage genome assembly and analysis, including safety checks for therapeutic use. We have an extensive collection of ESKAPE-pathogen phages available for licensing or purchase. We also maintain up to BSL3-level laboratory for lab services, including phage isolation and custom research projects.

Making high performance bioinformatics accessible - We help phage researchers and companies with our high performance automatic and manual phage and bacteria genome analysis.

Ritam Global is a leading global company that specializes in providing students with comprehensive study abroad services. We are dedicated to helping students achieve their academic goals by providing expert guidance and support throughout the entire process.

Our team of highly experienced and qualified overseas education consultants in philippines has the expertise and knowledge to assist students with everything from career counselling and course selection to visa guidance and application support.

With a commitment to excellence, personalized service, and a global network of trusted partners and institutions, Ritam Global is the go-to destination for students seeking quality study abroad experiences. Whether you are looking to study in Canada, Australia, UK, USA, or any other destination around the world, Ritam Global has the expertise and resources to help you make your dreams a reality.

Ritam Global is a leading global company that specializes in providing students with comprehensive study abroad services. We are dedicated to helping students achieve their academic goals by providing expert guidance and support throughout the entire process.

Our team of highly experienced and qualified overseas education consultants in philippines has the expertise and knowledge to assist students with everything from career counselling and course selection to visa guidance and application support.

With a commitment to excellence, personalized service, and a global network of trusted partners and institutions, Ritam Global is the go-to destination for students seeking quality study abroad experiences. Whether you are looking to study in Canada, Australia, UK, USA, or any other destination around the world, Ritam Global has the expertise and resources to help you make your dreams a reality.

Our mission is to improve animal and human health, through our natural, safe and environmentally sustainable phage-platform technology that reduces pathogens with no need of antibiotics.

ScyTek laboratories inc Biotech manufactures diagnostic reagents, Special Stains, Antibodies, Hematology, Immunohistochemistry, buffers, Microbiology, Hematoxlyn etc https://www.scytek.com

ScyTek Biotech Life Sciences manufactures diagnostic reagents, Special Stains, Antibodies, Hematology, Immunohistochemistry, buffers, Microbiology, Hematoxlyn etc
https://www.scytek.com

We provide best-in-class GMP/GLP analytical testing, formulation research and development, clinical manufacturing and clinical research services for the pharmaceutical, biopharmaceutical and medical device sectors. Our solutions match your biologics and small molecule needs and cover the complete life cycle – from exploratory development, testing, regulatory support, safety studies and clinical development, to commercial QC and post-market testing.

Utilizing a global network of laboratories and clinical trial facilities, our specialists deliver multifaceted, customer-centric programs at local and international levels. We help you to navigate your way to market while ensuring the optimization of drug exposure and product compliance with regulatory and industry standards and expectations.

With an increasing need to adopt agile, scalable resourcing models, we provide flexible sourcing models that let you focus on core competencies, improve overall performance and contain costs by leveraging our external management and quality assurance capabilities.

We are a consultancy with experience of medicinal products, medical devices and clinical trials. This include Quality Assurance, CMC, and regulatory affairs.

Provide natural antimicrobial solution for livestock.

Research and development of enzybiotics.

To promote and conduct phage therapy in Israel and worldwide

To provide standard operating procedures for bacteriophage researches and to do bacteriophage researches.

We are developing phage cocktails containing natural phages.

We aim to design and develop specialized, safe, and efficacious bacteriophage-based immunotherapeutics that can be accessed globally.

We envision a world where infectious diseases are prevented and cancers are cured, not treated. We endeavour to act locally and impact globally.

UK Phage Therapy will be a national specialist phage centre.

Working with industrial partners we will manufacture phages according to Good Manufacturing Practice (GMP) for:

• NHS patients

• Clinical trials

• Businesses

UKPT will be the national centre for clinical phage therapy in the UK

There is growing clinical demand for phage therapy in the UK and we will support the provision of phage therapy to patients whose clinical needs cannot be met by licensed alternatives

UKPT is also developing a clinical phage network to support clinicians across the UK

UKPT will enhance patient care and transform the way we treat bacterial infections in the UK

VectorB2B – One-Stop Shop provides highly qualified services of drug discovery and development from the bench to bedside (B2B).
VectorB2B gathers the scattered capacities of the Portuguese academic and industrial shareholders in the sector of health biotechnology to provide integrated services in the development of bacteriophage and endolysins products, namely:
• Efficacy studies
• Pre-clinical toxicology studies (GLP, non-GLP)
• Process development from lab scale to GMP manufacturing
• Pre-formulation and formulation
• Clinical trials (Phase I-III)
• Regulatory support and dossier preparation

Vésale Bioscience is a Belgian biotech, created in 2018 as a spin-out of Vésale Pharma.
We fight antibacterial multi-resistant infections (AMR) with our personalized phage therapy solutions:

1. We have developed a fast diagnostic tool Inteliphage®, an automated Phagogram®, which can be easily placed in hospital laboratories and that will recommend in a couple of hours (instead of days/weeks) the optimal phages association (2 or 3) from our phage library to fight the specific patient’s bacteria.
2. We will produce a library of phages in advance and speed deliver to hospitals the selected phages from the Phagogram® as API for tailored magistral preparations. This approach dramatically reduces the time-to-patient and increases the success rate of AMR treatments. This allows to treat acute and chronic infections at the hospital: already tested in more than 100 critically ill patients without major safety concerns. We expect to have our first sales in Europe in 2023.

The objective of VetoPhage is to finalize the « proof of concept » and develop innovative tools for the diagnosis and treatment of pathogenic bacteria in livestock and in aquaculture.

The aim of Vitalis Phage Therapy is to make phage therapy accessible as a treatment option to every person suffering from an antibiotic-resistant infection or chronic infection. Our activities include phage therapy awareness initiatives like our video podcast series “All About Phage Therapy”, establishing local treatment frameworks in India to enable people to access phage therapy without travelling to another country, establishing diagnostic testing with phages in India to provide quicker access to the phage therapy, and working with medical institutions to facilitate phage therapy for their patients.